What's in store today...
24th September 2014 00:00
by Lee Wild from interactive investor
Share on
did well in August. Shares in the drugs company surged by a quarter, and at the end of the month it bought the global rights to the oncology support therapy, Ethyol from . Ethyol treats dry mouth, a side-effect in patients undergoing post-operative radiation treatment for head and neck cancer, and generated revenue of $4.9 million in 2013.
Analysts' expectations: Investec Securities forecasts revenue of £126.2 million for the year to 30 June, driving pre-tax profit up by 13% to £25.1 million. "Whilst we think the shares are unlikely to recover to their early 2014 levels (675p), we think upside potential remains material and the downside risk is overdone," said the broker.
Find out what else the week has in store here.
Wednesday 24 September
Trading statements
Outsourcery, Proxama, Instem, Judges Scientific, Personal Group Holdings, Origin Enterprises, Clinigen Group, United Utilities Group.
AGM/EGM
First Property Group, Accumuli, Mirada , Continental Coal.